OPKO Health (NASDAQ: OPK) saw its shares tumble 5.47% in after-hours trading on Thursday following the release of its second quarter 2025 financial results. The healthcare company reported a mixed bag of results, with significant losses and missed revenue targets overshadowing a better-than-expected adjusted earnings per share.
The company reported a staggering net loss of $148.4 million for the quarter, with an operating loss of $60 million. Revenue from services came in at $101.1 million, contributing to total sales of $156.8 million. This figure fell short of analyst expectations of $165.744 million, representing a 13.94% decrease compared to the same period last year. The basic earnings per share (EPS) stood at a loss of $0.19.
Despite the overall negative results, there were some silver linings. OPKO's adjusted EPS of $(0.07) beat the analyst consensus estimate of $(0.11) by 35.78%. Additionally, the company's board authorized an additional $100 million for stock repurchases, potentially signaling confidence in the company's long-term prospects. However, these positive notes were not enough to offset investor concerns about the company's financial performance, leading to the significant after-hours stock price decline.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.